Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry.
Publication
, Journal Article
Chaudhary, R; Kreutz, RP; Bliden, KP; Tantry, US; Gurbel, PA
Published in: Thromb Haemost
November 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Thromb Haemost
DOI
EISSN
2567-689X
Publication Date
November 2020
Volume
120
Issue
11
Start / End Page
1594 / 1596
Location
Germany
Related Subject Headings
- Thrombophilia
- Thrombelastography
- SARS-CoV-2
- Role
- Patients
- Pandemics
- Intensive Care Units
- Humans
- Hemostasis
- Fibrinolytic Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Chaudhary, R., Kreutz, R. P., Bliden, K. P., Tantry, U. S., & Gurbel, P. A. (2020). Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry. Thromb Haemost, 120(11), 1594–1596. https://doi.org/10.1055/s-0040-1714217
Chaudhary, Rahul, Rolf P. Kreutz, Kevin P. Bliden, Udaya S. Tantry, and Paul A. Gurbel. “Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry.” Thromb Haemost 120, no. 11 (November 2020): 1594–96. https://doi.org/10.1055/s-0040-1714217.
Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA. Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry. Thromb Haemost. 2020 Nov;120(11):1594–6.
Chaudhary, Rahul, et al. “Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry.” Thromb Haemost, vol. 120, no. 11, Nov. 2020, pp. 1594–96. Pubmed, doi:10.1055/s-0040-1714217.
Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA. Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry. Thromb Haemost. 2020 Nov;120(11):1594–1596.
Published In
Thromb Haemost
DOI
EISSN
2567-689X
Publication Date
November 2020
Volume
120
Issue
11
Start / End Page
1594 / 1596
Location
Germany
Related Subject Headings
- Thrombophilia
- Thrombelastography
- SARS-CoV-2
- Role
- Patients
- Pandemics
- Intensive Care Units
- Humans
- Hemostasis
- Fibrinolytic Agents